Publications by Dr Martin Highley - ePrints

Browsing publications by Dr Martin Highley.

Newcastle Authors	Title	Year
Dr Yvette Drew Dr Martin Highley Julieann Sludden Dr James Murray Dr David Jamieson et al.	Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly (ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer	2016
Professor Ruth Plummer Dr Andrew Hughes Dr Martin Highley Dr Sathyarathna Gokul Professor Alan Calvert et al.	A phase I trial of ZD9331, a water-soluble, nonpolyglutamatable, thymidylate synthase inhibitor	2003
Huw Thomas Mike Cole Suzanne Elliott Professor Herbie Newell Professor Alan Calvert et al.	Randomized cross-over clinical trial to study potential pharmacokinetic interactions between cisplatin or carboplatin and etoposide	2002
Professor Alan Boddy Dr Martin Highley Dr John Fenwick Professor Alan Calvert	Estimation of glomerular filtration rate in cancer patients	2001
Professor Alan Boddy Melanie Griffin Julieann Sludden Huw Thomas Kevin Fishwick et al.	Pharmacological study of paclitaxel duration of infusion combined with GFR-based carboplatin in the treatment of ovarian cancer	2001
Professor Alan Boddy Melanie Griffin Julieann Sludden Huw Thomas Kevin Fishwick et al.	Paclitaxel and carboplatin dose-intensity and duration of infusion in the treatment of ovarian cancer	2000
Professor Alan Calvert Dr Martin Highley Professor John Lunec Professor Alan Boddy	Carboplatin and paclitaxel, alone and in combination: Dose escalation, measurement of renal function, and role of the p53 tumor suppressor gene	1999
Dr Martin Highley	Intravesical drug delivery - Pharmacokinetic and clinical considerations	1999
Dr Martin Highley	Pharmacokinetics and bioavailability of oral 5 '-deoxy-5-fluorouridine in cancer patients	1999
Dr Martin Highley Professor Ruth Plummer	Phase I study of BMS-184476, a new taxane analog, given weekly in patients with advanced malignancies	1999
Professor Ruth Plummer Professor Alan Calvert Dr Martin Highley	Phase I trial of ZD9331 in adult patients with refractory solid malignancies administered by 30-min infusion on days 1 and 8 with the cycle repeated every 3 weeks	1999